Clinical Trials
4 trialsNCT04665076 2020-12-11
Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Unknown
NCT04162119 2019-11-18
Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma
Chinese PLA General Hospital
Phase 2 Unknown
NCT04065308 2019-08-22
Dara_DCEP
Seoul National University Hospital
Phase 2 Unknown
NCT01199718 2011-06-15
Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
Cylene Pharmaceuticals
Phase 1 Unknown